Exact Sciences
EXAS
#1165
Rank
C$27.21 B
Marketcap
C$142.55
Share price
0.00%
Change (1 day)
118.68%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Earnings for Exact Sciences (EXAS)

Earnings in 2025 (TTM): -C$0.26 Billion

According to Exact Sciences's latest financial reports the company's current earnings are C$3.24 Billion. , an increase over its 2024 earnings that were of -C$1.38 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Exact Sciences from 2001 to 2025

Annual earnings

Year Earnings Change
2025 -C$0.25 Billion-82.05%
2024 -C$1.38 Billion435.05%
2023 -C$0.26 Billion-69.18%
2022 -C$0.84 Billion-25.77%
2021 -C$1.13 Billion1.68%
2020 -C$1.11 Billion271.17%
2019 -C$0.3 Billion58.99%
2018 -C$0.19 Billion20.89%
2017 -C$0.16 Billion-30.95%
2016 -C$0.23 Billion5.09%
2015 -C$0.22 Billion57.24%
2014 -C$0.14 Billion116.53%
2013 -C$62.91 Million
2011 -C$39.17 Million143.73%
2010 -C$16.07 Million27.85%
2009 -C$12.57 Million0.27%
2008 -C$12.54 Million-20.95%
2007 -C$15.86 Million-13.53%
2006 -C$18.34 Million-10.07%
2005 -C$20.4 Million-21.81%
2004 -C$26.09 Million-33.44%
2003 -C$39.19 Million-6.51%
2002 -C$41.92 Million17.95%
2001 -C$35.54 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sanofi
SNY
C$10.46 B-4,325.25%๐Ÿ‡ซ๐Ÿ‡ท France
Veracyte
VCYT
C$84.15 M-133.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
C$89.52 M-136.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
-C$0.57 Billion 129.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
-C$47.52 Million-80.81%๐Ÿ‡บ๐Ÿ‡ธ USA